Craniopharyngioma Clinical Trials

9 recruiting

Craniopharyngioma Trials at a Glance

12 actively recruiting trials for craniopharyngioma are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in Columbus, Miami, and Aurora. Lead sponsors running craniopharyngioma studies include Nationwide Children's Hospital, Eva Marie Erfurth, MD, PhD, and Deling Li.

Browse craniopharyngioma trials by phase

Treatments under study

About Craniopharyngioma Clinical Trials

Looking for clinical trials for Craniopharyngioma? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Craniopharyngioma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Craniopharyngioma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 2

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

CraniopharyngiomaCraniopharyngioma, ChildRecurrent Craniopharyngioma
Sabine Mueller, MD, PhD57 enrolled20 locationsNCT05465174
Recruiting
Phase 2

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital30 enrolled14 locationsNCT05233397
Recruiting
Phase 2

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital38 enrolled10 locationsNCT05286788
Recruiting
Phase 1Phase 2

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Craniopharyngiomas
Nanfang Hospital, Southern Medical University57 enrolled1 locationNCT06970145
Recruiting
Not Applicable

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

Craniopharyngioma
Deling Li20 enrolled1 locationNCT07177482
Recruiting
Phase 2

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

CraniopharyngiomaHypothalamic ObesityHypothalamic Tumor
Seattle Children's Hospital24 enrolled2 locationsNCT06299891
Recruiting

Long-Term Longitudinal QoL in Patients Undergoing EEA

ChondrosarcomaMeningiomaPituitary Tumor+5 more
Ohio State University400 enrolled1 locationNCT04087902
Recruiting

The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction

MeningiomaPituitary AdenomaCraniopharyngioma+3 more
Universitaire Ziekenhuizen KU Leuven154 enrolled3 locationsNCT06874426
Recruiting

Craniopharyngioma and Pregnancies

Craniopharyngioma
Assistance Publique - Hôpitaux de Paris100 enrolled1 locationNCT06801756
Recruiting

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

GerminomaMeningiomaAdenoma+9 more
Maastricht Radiation Oncology1,500 enrolled3 locationsNCT04648462
Recruiting

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts

ObesityCraniopharyngioma
Klinikum Oldenburg gGmbH90 enrolled1 locationNCT04158284
Recruiting
Phase 2

Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma

Craniopharyngioma
Eva Marie Erfurth, MD, PhD25 enrolled1 locationNCT05525273